Cargando…
Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice
Nonalcoholic fatty liver disease (NAFLD) which is a leading cause of chronic liver diseases lacks effective treatment. Tamoxifen has been proven to be the first-line chemotherapy for several solid tumors in clinics, however, its therapeutic role in NAFLD has never been elucidated before. In vitro ex...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981902/ https://www.ncbi.nlm.nih.gov/pubmed/36864030 http://dx.doi.org/10.1038/s41392-022-01299-y |
_version_ | 1784900206472462336 |
---|---|
author | Fang, Zhiqiang Xu, Hao Duan, Juanli Ruan, Bai Liu, Jingjing Song, Ping Ding, Jian Xu, Chen Li, Zhiwen Dou, Kefeng Wang, Lin |
author_facet | Fang, Zhiqiang Xu, Hao Duan, Juanli Ruan, Bai Liu, Jingjing Song, Ping Ding, Jian Xu, Chen Li, Zhiwen Dou, Kefeng Wang, Lin |
author_sort | Fang, Zhiqiang |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) which is a leading cause of chronic liver diseases lacks effective treatment. Tamoxifen has been proven to be the first-line chemotherapy for several solid tumors in clinics, however, its therapeutic role in NAFLD has never been elucidated before. In vitro experiments, tamoxifen protected hepatocytes against sodium palmitate-induced lipotoxicity. In male and female mice fed with normal diets, continuous tamoxifen administration inhibited lipid accumulation in liver, and improved glucose and insulin intolerance. Short-term tamoxifen administration largely improved hepatic steatosis and insulin resistance, however, the phenotypes manifesting inflammation and fibrosis remained unchanged in abovementioned models. In addition, mRNA expressions of genes related to lipogenesis, inflammation, and fibrosis were downregulated by tamoxifen treatment. Moreover, the therapeutic effect of tamoxifen on NAFLD was not gender or ER dependent, as male and female mice with metabolic disorders shared no difference in response to tamoxifen and ER antagonist (fulvestrant) did not abolish its therapeutic effect as well. Mechanistically, RNA sequence of hepatocytes isolated from fatty liver revealed that JNK/MAPK signaling pathway was inactivated by tamoxifen. Pharmacological JNK activator (anisomycin) partially deprived the therapeutic role of tamoxifen in treating hepatic steatosis, proving tamoxifen improved NAFLD in a JNK/MAPK signaling-dependent manner. |
format | Online Article Text |
id | pubmed-9981902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99819022023-03-04 Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice Fang, Zhiqiang Xu, Hao Duan, Juanli Ruan, Bai Liu, Jingjing Song, Ping Ding, Jian Xu, Chen Li, Zhiwen Dou, Kefeng Wang, Lin Signal Transduct Target Ther Article Nonalcoholic fatty liver disease (NAFLD) which is a leading cause of chronic liver diseases lacks effective treatment. Tamoxifen has been proven to be the first-line chemotherapy for several solid tumors in clinics, however, its therapeutic role in NAFLD has never been elucidated before. In vitro experiments, tamoxifen protected hepatocytes against sodium palmitate-induced lipotoxicity. In male and female mice fed with normal diets, continuous tamoxifen administration inhibited lipid accumulation in liver, and improved glucose and insulin intolerance. Short-term tamoxifen administration largely improved hepatic steatosis and insulin resistance, however, the phenotypes manifesting inflammation and fibrosis remained unchanged in abovementioned models. In addition, mRNA expressions of genes related to lipogenesis, inflammation, and fibrosis were downregulated by tamoxifen treatment. Moreover, the therapeutic effect of tamoxifen on NAFLD was not gender or ER dependent, as male and female mice with metabolic disorders shared no difference in response to tamoxifen and ER antagonist (fulvestrant) did not abolish its therapeutic effect as well. Mechanistically, RNA sequence of hepatocytes isolated from fatty liver revealed that JNK/MAPK signaling pathway was inactivated by tamoxifen. Pharmacological JNK activator (anisomycin) partially deprived the therapeutic role of tamoxifen in treating hepatic steatosis, proving tamoxifen improved NAFLD in a JNK/MAPK signaling-dependent manner. Nature Publishing Group UK 2023-03-03 /pmc/articles/PMC9981902/ /pubmed/36864030 http://dx.doi.org/10.1038/s41392-022-01299-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Fang, Zhiqiang Xu, Hao Duan, Juanli Ruan, Bai Liu, Jingjing Song, Ping Ding, Jian Xu, Chen Li, Zhiwen Dou, Kefeng Wang, Lin Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice |
title | Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice |
title_full | Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice |
title_fullStr | Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice |
title_full_unstemmed | Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice |
title_short | Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice |
title_sort | short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through jnk/mapk in mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981902/ https://www.ncbi.nlm.nih.gov/pubmed/36864030 http://dx.doi.org/10.1038/s41392-022-01299-y |
work_keys_str_mv | AT fangzhiqiang shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT xuhao shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT duanjuanli shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT ruanbai shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT liujingjing shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT songping shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT dingjian shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT xuchen shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT lizhiwen shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT doukefeng shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice AT wanglin shorttermtamoxifenadministrationimproveshepaticsteatosisandglucoseintolerancethroughjnkmapkinmice |